BACKGROUND:Oligosaccharides may alter postnatal immune development by influencing the constitution of gastrointestinal bacterial flora. AIMS: To investigate the effect of a prebiotic mixture of galacto- and long chain fructo-oligosaccharides on the incidence of atopic dermatitis (AD) during the first six months of life in formula fed infants at high risk of atopy. METHODS: Prospective, double-blind, randomised, placebo controlled trial; 259 infants at risk for atopy were enrolled. A total of 102 infants in the prebiotic group and 104 infants in theplacebo group completed the study. If bottle feeding was started, the infant was randomly assigned to one of two hydrolysed protein formula groups (0.8 g/100 ml prebiotics or maltodextrine as placebo). All infants were examined for clinical evidence of atopic dermatitis. In a subgroup of 98 infants, faecal flora was analysed. RESULTS: Ten infants (9.8%; 95 CI 5.4-17.1%) in the intervention group and 24 infants (23.1%; 95 CI 16.0-32.1%) in the control group developed AD. The severity of the dermatitis was not affected by diet. Prebiotic supplements were associated with a significantly higher number of faecal bifidobacteria compared with controls but there was no significant difference in lactobacilli counts. CONCLUSION: Results show for the first time a beneficial effect of prebiotics on the development of atopic dermatitis in a high risk population of infants. Although the mechanism of this effect requires further investigation, it appears likely that oligosaccharides modulate postnatal immune development by altering bowel flora and have a potential role in primary allergy prevention during infancy.
RCT Entities:
BACKGROUND:Oligosaccharides may alter postnatal immune development by influencing the constitution of gastrointestinal bacterial flora. AIMS: To investigate the effect of a prebiotic mixture of galacto- and long chain fructo-oligosaccharides on the incidence of atopic dermatitis (AD) during the first six months of life in formula fed infants at high risk of atopy. METHODS: Prospective, double-blind, randomised, placebo controlled trial; 259 infants at risk for atopy were enrolled. A total of 102 infants in the prebiotic group and 104 infants in the placebo group completed the study. If bottle feeding was started, the infant was randomly assigned to one of two hydrolysed protein formula groups (0.8 g/100 ml prebiotics or maltodextrine as placebo). All infants were examined for clinical evidence of atopic dermatitis. In a subgroup of 98 infants, faecal flora was analysed. RESULTS: Ten infants (9.8%; 95 CI 5.4-17.1%) in the intervention group and 24 infants (23.1%; 95 CI 16.0-32.1%) in the control group developed AD. The severity of the dermatitis was not affected by diet. Prebiotic supplements were associated with a significantly higher number of faecal bifidobacteria compared with controls but there was no significant difference in lactobacilli counts. CONCLUSION: Results show for the first time a beneficial effect of prebiotics on the development of atopic dermatitis in a high risk population of infants. Although the mechanism of this effect requires further investigation, it appears likely that oligosaccharides modulate postnatal immune development by altering bowel flora and have a potential role in primary allergy prevention during infancy.
Authors: Hansjörg Schmelzle; Stefan Wirth; Heino Skopnik; Michael Radke; Jan Knol; Heinz-Michael Böckler; Anja Brönstrup; John Wells; Christoph Fusch Journal: J Pediatr Gastroenterol Nutr Date: 2003-03 Impact factor: 2.839
Authors: Andrea von Berg; Sibylle Koletzko; Armin Grübl; Birgit Filipiak-Pittroff; H-Erich Wichmann; Carl Peter Bauer; Dietrich Reinhardt; Dietrich Berdel Journal: J Allergy Clin Immunol Date: 2003-03 Impact factor: 10.793
Authors: Antonella Muraro; Sten Dreborg; Susanne Halken; Arne Høst; Bodo Niggemann; Rob Aalberse; Syed H Arshad; Andrea von Berg; Kai-Håkon Carlsen; Karel Duschén; Philippe Eigenmann; David Hill; Catherine Jones; Michael Mellon; Göran Oldeus; Arnold Oranje; Cristina Pascual; Susan Prescott; Hugh Sampson; Magnus Svartengren; Yvan Vandenplas; Ulrich Wahn; Jill A Warner; John O Warner; Magnus Wickman; Robert S Zeiger Journal: Pediatr Allergy Immunol Date: 2004-06 Impact factor: 6.377
Authors: Megan M Moore; Sheryl L Rifas-Shiman; Janet W Rich-Edwards; Ken P Kleinman; Carlos A Camargo; Diane R Gold; Scott T Weiss; Matthew W Gillman Journal: Pediatrics Date: 2004-03 Impact factor: 7.124
Authors: Glenn R Gibson; Robert Hutkins; Mary Ellen Sanders; Susan L Prescott; Raylene A Reimer; Seppo J Salminen; Karen Scott; Catherine Stanton; Kelly S Swanson; Patrice D Cani; Kristin Verbeke; Gregor Reid Journal: Nat Rev Gastroenterol Hepatol Date: 2017-06-14 Impact factor: 46.802